Athos Capital »

Avidity Biosciences Ord shares owned by Athos Capital

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by Athos Capital from 13F filings

Historical chart of Athos Capital investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by Athos Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by Athos Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $13M 185k 72.13

More positions owned by Athos Capital

Kenvue (KVUE)
Hello Group Ads (MOMO)
Ke Hldgs Sponsored Ads (BEKE)
Avidity Biosciences Ord (RNA)
Hologic (HOLX)
Clearwater Analytics Hldgs I Cl A Call Option (CWAN)
Chart Industries (GTLS)
Cidara Therapeutics Com New (CDTX)
Amicus Therapeutics (FOLD)
PNM Resources (TXNM)
Liberty Broadband Corp Com Ser C (LBRDK)
Norfolk Southern (NSC)
Janus Henderson Group Ord Shs (JHG)
Joyy Ads Repstg Com A (JOYY)
Confluent Class A Com (CFLT)

View all positions for Athos Capital

Top funds holding Avidity Biosciences Ord

FMR
Henderson Group
Vanguard Group
Wellington Management Company
BlackRock
RA Capital Management
venBio Select Advisor
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Norges Bank Investment Management
Bellevue Group
Glazer Capital
UBS Group
Susquehanna International

View all funds holding Avidity Biosciences Ord